Ranbaxy Laboratories Limited: At the Crossroads
通常価格
¥1,342 JPY
通常価格
セール価格
¥1,342 JPY
単価
あたり
税込み。
受取状況を読み込めませんでした
The case describes challenges facing Ranbaxy, the third largest pharmaceutical company in India, as it attempts to move from being a generics marketer, to a player in the branded drugs business. The case focuses on issues relating to the launch of Cifran OD, Ranbaxy's first drug based on a patented new drug delivery system.
【書誌情報】
ページ数:21ページ
サイズ:A4
商品番号:HBSP-INS739
発行日:2003/1/10
登録日:2015/9/28
